The Philippine Economic Zone Authority (PEZA) said over the weekend it released the guidelines for the registration of ...

Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

India aims for Rs 17,000 crore investment in pharma R&D by FY28 through PRIP scheme, focusing on innovation and growth.

Tata Motors leads Nifty 100 companies in R&D spending, focusing on mobility solutions and alternative fuel technologies.

PRIP aims to transform India into a global powerhouse for R&D in the pharma and MedTech sector, with a total financial outlay of ₹5,000 crore – made up of two components. The first component ...

R&amp,D outsourcing involves pharmaceutical companies subcontracting parts of their R&amp,D efforts to third-party service providers. Small or mid-sized pharmaceutical or biotech houses may use ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

set up a pharmaceutical business in 1876. He was a pioneer of new methods in the industry, being one of the first to focus on R&D as well as manufacturing. Another military man in the drugs ...

The Department of Pharmaceuticals has invited expressions of interest for project funding under the PRIP scheme, aiming to transform India into a global R&D hub in the Pharma MedTech sector.

Finnish drugmaker Orion Corporation has announced that it is establishing a new research and development (R&D) center in Cambridge, UK, during 2025 to accelerate its global growth strategy and the ...

Our Bureau, New Delhi Monday, March 10, 2025, 17:10 Hrs [IST] The Department of Pharmaceuticals (DoP) has released the Expre ...